2 BioPharma Catalyst Trades And 1 Strong Acquisition Target Rumored To Be In Play [View article]
You might be forgetting Walk that politics play a huge role, and advocacy groups a long with Obama Care. This is the type of drug the FDA tends to get more political with, because it effects so very few people - young boys. You might want to consider this factor.
No Carsons, I was wrong predicting a positive Adcomm. Me and my followers still made a good deal of money, u would too if u follow me on twitter and my live show. I gave a trading thesis, and also sold the run up over 8, lost on calls, but won more trading the bounce from 2.50 to 2.95 upon open - all a thesis which I discussed beforehand, and gave proof of thesis on twitter. This is stocks, trading, and money, and good traders make money regardless of a fundamental outcome. Have a nice day!
AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential [View article]
I made 20,000 trading the stock. I gave a run up target price of 8.50. it hit 8.40. I tweeted when I sold over 8 dollars, my followers did the same, I explained the notes would likely cause a sell off. I did buy 2500 bucks worth of calls - lost, traded a poop ton of shares for a bottom bounce, made on that, It never ceases to amaze me - that which a person is grossly guilty of, they vehemently accuse others of.
AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential [View article]
And actually, you are a hematologist, you are not an oncologist, as your other posts clearly have professed. Well respected doctors who are good at what they do, do not "troll" seeking alpha. have a nice day!
AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential [View article]
That's nice Doc, stick to what you know, small cap bios aren't investments, they are trades. Suggesting a small cap company developmental company as an "investment" is not wise.
My followers who followed my trading thesis made money, on run up, failure, and bounce afterwards. By the time you read this, it's likely your comments will be removed, as they are personal in nature. I have a top notch record of trade calling and long term price target predictions, as anyone can verify. I do not appreciate your tone and total unprofessional rant here. Please act like a good Doctor should. thanks!
Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion [View article]
PPHM? heh, sorry bro, I will never do any positive article on that company as long as current management remains in place. I do articles in picks I believe in, not simply to " move a stock price" I believe in offering the best picks I can possibly give. If I wrote on PPHM, I would be betraying what I believe about the company's poor management. Let me know if they dump that management, and I will consider it.. Sorry bro.
AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential [View article]
the FDA originally asked AVEO to consider another trial. AVEO addressed that, as other OS trends in same segment showed no benefit, or a slight trend down of no statistical difference. OS trend explained. Now, for reference, read the following tweet from me with a quote from a non voting member of the Adcomm tomorrow >>
About the Roth capital? All analysts notes have that disclaimer; "may engage" if they are investment banks as well.
Don't know what to tell you, that is developmental biotech. ARIA loses a ton more and has a 3B market cap. this one now as a 110M market cap. triple of that is $330M market cap. think market cap, not price.
You are correct -- the 3 months or less does refer to guidance, which is a huge catalyst event, but I should have made that more clear. Thanks for pointing this out!
honestly, no, because I dont like Vibex QST. I cant say in 2014 -- if company does not get too agressive with QST, considering other factors that loko mentions, perhaps, 12 a share or so.
2 BioPharma Catalyst Trades And 1 Strong Acquisition Target Rumored To Be In Play [View article]
2 BioPharma Catalyst Trades And 1 Strong Acquisition Target Rumored To Be In Play [View article]
Quickly Approaching Biopharma Catalyst Events [View article]
Have a nice day!
AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential [View article]
AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential [View article]
AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential [View article]
My followers who followed my trading thesis made money, on run up, failure, and bounce afterwards. By the time you read this, it's likely your comments will be removed, as they are personal in nature. I have a top notch record of trade calling and long term price target predictions, as anyone can verify. I do not appreciate your tone and total unprofessional rant here. Please act like a good Doctor should. thanks!
Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion [View article]
AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential [View article]
http://bit.ly/14UYRi8
Quickly Approaching Biopharma Catalyst Events [View article]
Quickly Approaching Biopharma Catalyst Events [View article]
Quickly Approaching Biopharma Catalyst Events [View article]
Don't know what to tell you, that is developmental biotech. ARIA loses a ton more and has a 3B market cap. this one now as a 110M market cap. triple of that is $330M market cap. think market cap, not price.
Quickly Approaching Biopharma Catalyst Events [View article]
Quickly Approaching Biopharma Catalyst Events [View article]
Cleveland BioLabs Offers Medical Countermeasures Against Potential Terrorist Attacks [View article]
Thursday's BioPharma Trade Movers [View article]